• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Indivior Pharmaceuticals Inc. (INDV)

Common Shares
Sell: $33.34|Buy: $33.99|Change: 0.75 (2.30%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Address

234 Bath Road
Slough
Berkshire
GBR
SL1 4EE

Telephone

+44 1753217800

Website

https://www.indivior.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Indivior Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20262027-02-26T08:00:00
Indivior Pharmaceuticals Inc Fourth Quarter Earnings Results for 20262027-02-26T07:00:00
Indivior Pharmaceuticals Inc Annual Report for 20262027-02-26T00:00:00
Indivior PLC Third Quarter Earnings Conference Call for 20262026-10-30T08:00:00
Indivior PLC Third Quarter Earnings Results for 20262026-10-30T07:00:00
Indivior PLC Second Quarter Earnings Conference Call for 20262026-07-31T08:00:00
Indivior PLC Second Quarter Earnings Results for 20262026-07-31T07:00:00
Indivior PLC Annual General Meeting for 20262026-05-08T12:00:00
Indivior PLC First Quarter Earnings Conference Call for 20262026-04-24T08:00:00
Indivior PLC First Quarter Earnings Results for 20262026-04-24T02:00:00
Barclays 28th Annual Global Healthcare Conference2026-03-10T14:00:00

Previous key dates

NameKey Date
Barclays 28th Annual Global Healthcare Conference2026-03-10T14:00:00
Indivior Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20252026-02-26T08:00:00
Indivior Pharmaceuticals Inc Fourth Quarter Earnings Results for 20252026-02-26T07:00:00
Indivior Pharmaceuticals Inc Annual Report for 20252026-02-26T00:00:00
Piper Sandler 37th Annual Healthcare Conference2025-12-02T15:30:00
Stifel 2025 Healthcare Conference2025-11-13T08:40:00
Indivior PLC Third Quarter Earnings Conference Call for 20252025-10-30T08:00:00
Indivior PLC Third Quarter Earnings Results for 20252025-10-30T07:00:00
H.C. Wainwright 27th Annual Global Investment Conference2025-09-09T00:00:00
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-08T09:15:00
Indivior PLC Second Quarter Earnings Conference Call for 20252025-07-31T08:00:00
Indivior PLC Second Quarter Earnings Results for 20252025-07-31T07:00:00
Jefferies Global Healthcare Conference2025-06-04T09:55:00
Indivior PLC Annual General Meeting for 20252025-05-08T12:00:00
Indivior PLC First Quarter Earnings Conference Call for 20252025-04-24T08:00:00
Indivior PLC First Quarter Earnings Results for 20252025-04-24T02:00:00
Indivior PLC Annual Report for 20242025-03-03T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.